MicroRNAs in Methamphetamine: Addiction, Neurotoxicity, and Therapeutic Potential

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Yacoubou Abdoul Razak Mahaman, An‐Ping Ye, Ya‐Xian Zhang, Ming‐Yu Chen, Fang Huang, Rong Liu, Ying‐Yan Fang, Xiaochuan Wang
Natura: Artículo Open Access
Pubblicazione: Wiley 2026
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867019007145541633
author Yacoubou Abdoul Razak Mahaman
An‐Ping Ye
Ya‐Xian Zhang
Ming‐Yu Chen
Fang Huang
Rong Liu
Ying‐Yan Fang
Xiaochuan Wang
author_facet Yacoubou Abdoul Razak Mahaman
An‐Ping Ye
Ya‐Xian Zhang
Ming‐Yu Chen
Fang Huang
Rong Liu
Ying‐Yan Fang
Xiaochuan Wang
Yacoubou Abdoul Razak Mahaman
An‐Ping Ye
Ya‐Xian Zhang
Ming‐Yu Chen
Fang Huang
Rong Liu
Ying‐Yan Fang
Xiaochuan Wang
collection Wiley Open Access
contents MicroRNAs in Methamphetamine: Addiction, Neurotoxicity, and Therapeutic Potential Yacoubou Abdoul Razak Mahaman An‐Ping Ye Ya‐Xian Zhang Ming‐Yu Chen Fang Huang Rong Liu Ying‐Yan Fang Xiaochuan Wang MedComm – Future Medicine ABSTRACT Drug addiction is a debilitating condition that causes severe mental and physical impairments. Methamphetamine (METH) is one of the most commonly abused psychostimulants, mainly affecting the brain by releasing dopamine and serotonin. METH addiction has become a serious public health issue, and there is currently no specific treatment available. Although scientists have a good understanding of the mechanisms underlying drug addiction, including METH, our current biological and molecular knowledge of addiction is still incomplete. There is substantial evidence that addiction‐related changes are primarily mediated through gene expression regulation. Interestingly, the involvement of microRNAs (miRNAs) in this process could enhance our understanding of the molecular mechanisms underlying METH addiction. Therefore, further understanding the mechanisms behind METH‐induced differential changes in miRNAs, along with their pharmacological and genetic manipulation, could lead to promising new treatments for METH addiction. In this study, we first summarized epidemiological data and the addictive and neurotoxic mechanisms of METH, extensively reviewed studies on miRNA expression changes, discussed potential miRNA‐targeted therapeutic interventions for METH addiction, and outlined future research directions. We believe this study will provide a clearer understanding of the role of miRNAs in METH addiction and may help scientists develop more effective therapeutic strategies. 10.1002/mef2.70049 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/mef2.70049
format Artículo Open Access
id wiley_oa_10_1002_mef2_70049
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2026
publisher Wiley
record_format wiley_oa
spellingShingle MicroRNAs in Methamphetamine: Addiction, Neurotoxicity, and Therapeutic Potential
Yacoubou Abdoul Razak Mahaman
An‐Ping Ye
Ya‐Xian Zhang
Ming‐Yu Chen
Fang Huang
Rong Liu
Ying‐Yan Fang
Xiaochuan Wang
MedComm – Future Medicine
MicroRNAs in Methamphetamine: Addiction, Neurotoxicity, and Therapeutic Potential Yacoubou Abdoul Razak Mahaman An‐Ping Ye Ya‐Xian Zhang Ming‐Yu Chen Fang Huang Rong Liu Ying‐Yan Fang Xiaochuan Wang MedComm – Future Medicine ABSTRACT Drug addiction is a debilitating condition that causes severe mental and physical impairments. Methamphetamine (METH) is one of the most commonly abused psychostimulants, mainly affecting the brain by releasing dopamine and serotonin. METH addiction has become a serious public health issue, and there is currently no specific treatment available. Although scientists have a good understanding of the mechanisms underlying drug addiction, including METH, our current biological and molecular knowledge of addiction is still incomplete. There is substantial evidence that addiction‐related changes are primarily mediated through gene expression regulation. Interestingly, the involvement of microRNAs (miRNAs) in this process could enhance our understanding of the molecular mechanisms underlying METH addiction. Therefore, further understanding the mechanisms behind METH‐induced differential changes in miRNAs, along with their pharmacological and genetic manipulation, could lead to promising new treatments for METH addiction. In this study, we first summarized epidemiological data and the addictive and neurotoxic mechanisms of METH, extensively reviewed studies on miRNA expression changes, discussed potential miRNA‐targeted therapeutic interventions for METH addiction, and outlined future research directions. We believe this study will provide a clearer understanding of the role of miRNAs in METH addiction and may help scientists develop more effective therapeutic strategies. 10.1002/mef2.70049 http://creativecommons.org/licenses/by/4.0/
title MicroRNAs in Methamphetamine: Addiction, Neurotoxicity, and Therapeutic Potential
topic MedComm – Future Medicine
url https://onlinelibrary.wiley.com/doi/10.1002/mef2.70049